BMC plans expansion in the North

Threat of terror to business is a global one, CEO tells 'Post.'

September 19, 2006 08:58
1 minute read.
bob beauchamp 88 298

bob beauchamp 88 298. (photo credit: Courtesy)

With productivity remaining near-unaffected during the war in Lebanon, enterprise management giant BMC Software foresees continued growth in its Israel business, especially in its activities in the North. "Our investment here is growing and I believe that we will grow, particularly in northern Israel," Bob Beauchamp, president and chief executive officer of BMC, told The Jerusalem Post. "I believe we will grow here [in the North] because we use this for some key new incubator research projects." The company employees some 450 people at its research and development center in Tel Aviv, its biggest facility outside the US, and some 120 employees at another R&D center in Tel Hai. BMC Israel general manager Zehava Simon confirmed the Tel Hai facility was looking to increase its staff by 10 percent immediately and that it planned to boost its head count there by 40% to 50% within two years. The Tel Hai center was shut down through most of the war and Beauchamp said he was visiting primarily to express support for the employees after the conflict. "There was almost no productivity loss what so ever - I think less than a half of one day. Even for our activities here in Tel Hai, as our plans for such an event were brought into action," Beauchamp said. During that time, he said, some employees were transferred to Tel Aviv, others worked from home and Tel Hai's IT infrastructure was switched over to other facilities. Since first investing in Israel in 1999 with its purchase of New Dimension, BMC has spent more than $1 billion on acquisitions in the country. Earlier this year BMC added to that by buying Identify Software for $150 million to form the base of its transaction management business. While Beauchamp insisted the conflict did not change the company's view of Israel as a "very good investment," he said its concerns about terror and war "had spread to a global level." "I don't think that anywhere in the world is safe right now. We have offices in 38 countries and customers in over 100 countries and any of those countries we do business in could be affected by terrorism or war," he said. "What we've seen in Israel is that our employees there are particularly skilled at maintaining operations, even when adversity strikes."

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection